<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bjornstad P</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>JDRF</funding><pagination>831-839</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5860840</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(4)</volume><pubmed_abstract>OBJECTIVE:Central adiposity is considered to be an important cardiorenal risk factor in the general population and in type 1 diabetes. We sought to determine the relationship between central adiposity and intrarenal hemodynamic function in adults with long-standing type 1 diabetes with and without diabetic nephropathy (DN). RESEARCH DESIGN AND METHODS:Patients with type 1 diabetes (n = 66, duration ≥50 years) and age-/sex-matched control subjects (n = 73) were studied. The cohort was stratified into 44 DN Resistors (estimated glomerular filtration rate [eGFR] >60 mL/min/1.73 m2 and &lt;30 mg/day urine albumin) and 22 patients with DN (eGFR ≤60 mL/min/1.73 m2 or ≥30 mg/day urine albumin). Intrarenal hemodynamic function (glomerular filtration rate for inulin [GFRINULIN], effective renal plasma</pubmed_abstract><journal>Diabetes care</journal><pubmed_title>Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.</pubmed_title><pmcid>PMC5860840</pmcid><funding_grant_id>T32 DK063687</funding_grant_id><funding_grant_id>17-2013-312</funding_grant_id><funding_grant_id>K23 DK116720</funding_grant_id><funding_grant_id>T32-DK063687</funding_grant_id><pubmed_authors>Tse J</pubmed_authors><pubmed_authors>Cham L</pubmed_authors><pubmed_authors>Alhuzaim ON</pubmed_authors><pubmed_authors>Paul N</pubmed_authors><pubmed_authors>Lovshin JA</pubmed_authors><pubmed_authors>Lytvyn Y</pubmed_authors><pubmed_authors>Farooqi MA</pubmed_authors><pubmed_authors>Brent MH</pubmed_authors><pubmed_authors>Weisman A</pubmed_authors><pubmed_authors>Boulet G</pubmed_authors><pubmed_authors>Orszag A</pubmed_authors><pubmed_authors>Scarr D</pubmed_authors><pubmed_authors>Cherney DZI</pubmed_authors><pubmed_authors>Lai V</pubmed_authors><pubmed_authors>Bjornstad P</pubmed_authors><pubmed_authors>Perkins BA</pubmed_authors><pubmed_authors>Lovblom LE</pubmed_authors><pubmed_authors>Keenan HA</pubmed_authors><pubmed_authors>Bril V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.</name><description>OBJECTIVE:Central adiposity is considered to be an important cardiorenal risk factor in the general population and in type 1 diabetes. We sought to determine the relationship between central adiposity and intrarenal hemodynamic function in adults with long-standing type 1 diabetes with and without diabetic nephropathy (DN). RESEARCH DESIGN AND METHODS:Patients with type 1 diabetes (n = 66, duration ≥50 years) and age-/sex-matched control subjects (n = 73) were studied. The cohort was stratified into 44 DN Resistors (estimated glomerular filtration rate [eGFR] >60 mL/min/1.73 m2 and &lt;30 mg/day urine albumin) and 22 patients with DN (eGFR ≤60 mL/min/1.73 m2 or ≥30 mg/day urine albumin). Intrarenal hemodynamic function (glomerular filtration rate for inulin [GFRINULIN], effective renal plasma</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2025-04-05T15:14:02.235Z</modification><creation>2019-06-06T19:09:55Z</creation></dates><accession>S-EPMC5860840</accession><cross_references><pubmed>29437821</pubmed><doi>10.2337/dc17-2475</doi></cross_references></HashMap>